
UC San Diego research connects bile-acid patterns in centenarians with an enzyme tested in aged mice. Understand the findings and their limits.

On November 16, 2026, UC San Diego researchers published a study in Cell Metabolism linking bile salt hydrolase activity in gut microbes with exceptional human longevity. The team also reported improved metabolic measures after increasing this enzyme activity in aged mice.
The scientific starting point was that bile acids do more than help digest fats. As the UC San Diego report explains, the liver makes these substances and they also act as signaling molecules. That means they participate in chemical communication as well as digestion.
Gut microbes can change bile acids through the activity of an enzyme called bile salt hydrolase, or BSH. The study focused on this modifying activity. Its central question concerned a particular job performed by microbes rather than the gut microbiome as an undifferentiated whole.
That background matters when interpreting the announcement. The researchers were building on an existing biological connection between digestion and metabolism. They then asked whether patterns involving this microbial activity were associated with exceptional longevity and what happened when they increased it experimentally.
This is a more specific question than whether a microbiome looks different with age. It asks what a particular difference might be doing. DigestGenius’s resource on eating patterns and microbial activity provides broader context for thinking about the microbiome as an active biological system.
The UC San Diego team approached the question through human data and an experiment in aged mice. These parts of the study examined related biology in different ways: one compared existing measurements across human groups while the other deliberately increased BSH production.
The focus on bile-acid modification and longevity puts a microbial chemical process at the center of the aging question. The details of each part explain why the researchers consider that process worth further investigation.
According to UC San Diego, the researchers re-examined publicly available data that included bile-acid measurements from 48 young adults, 107 older adults, and 125 centenarians. The centenarians had higher ratios of certain modified bile acids than either comparison group.
The team also examined microbiome data. It found greater abundance of a gene associated with BSH activity in the centenarians than in the older-adult group.
These observations concerned related but distinct measurements. One described the balance of certain bile acids. The other described a microbial gene associated with the enzyme that modifies them.
That distinction keeps the finding precise. The reported pattern was not simply that centenarians had more gut bacteria or a generally superior microbiome. It involved particular bile-acid ratios and a gene linked to a specific microbial function.
In the animal research, aging was associated with increased BSH-related microbial activity and greater modification of bile acids. The team then engineered a gut-native bacterial strain to produce BSH continuously. Researchers introduced that strain into 82-week-old mice.
The comparison group received a matched control bacterium. Adding sustained BSH production was the feature being tested rather than attempting to replace the entire microbial community.
About 20 weeks after treatment, the mice receiving BSH-producing bacteria showed improved insulin sensitivity compared with controls. They also had modestly improved glucose tolerance. These measurements concern how the body responds to insulin and handles glucose.
By 32 weeks, the researchers reported changes consistent with lower body weight and fat mass and greater lean mass in the treated mice. The wording matters: these were reported body-composition changes within the animal experiment.
The UC San Diego report also described increased use of fat for energy and improved mitochondrial function. Other findings involved changes in gene activity associated with inflammation and the body’s internal clock.
Together, these results gave the researchers several metabolic outcomes to investigate. They moved the work beyond simply observing a difference in microbial measurements by testing a defined bacterial function in an experimental setting.
Senior author Amir Zarrinpar said some microbiome changes with aging “may actually represent the body’s attempt to preserve metabolic health.” This frames an age-related change as a possible compensation rather than automatically treating it as deterioration.
The biological question therefore becomes more precise. If a microbial function changes with age, researchers need to understand what that function does before deciding how to interpret the change.
That is the main conceptual contribution of this study. It directs attention toward microbial activity and its relationship with the host’s metabolism. For broader background, DigestGenius’s resource on microbiome changes across aging places this research question within the wider topic.
The human comparison and the mouse experiment contribute different kinds of evidence. Their boundaries are essential to understanding how far the findings reach.
The researchers reanalyzed existing human data rather than assigning people to a BSH intervention. The centenarian findings therefore do not establish that BSH activity caused exceptional longevity.
The researchers identify the central unresolved question directly: increased BSH activity could be a marker of healthy aging, a contributor to it, or both. Finding the activity among exceptionally long-lived people does not settle which explanation is correct.
The engineered bacterial intervention was tested in aged mice rather than people. The reported metabolic changes do not establish equivalent benefits for human health.
The researchers also emphasized that the findings do not show that the engineered bacteria extend lifespan. Improved metabolic measurements and longer life are different outcomes. Centenarians and aged mice are also not directly comparable, as the team cautioned.
The study does not establish that higher BSH activity is beneficial in every context. The researchers plan to examine how different forms of the enzyme affect bile-acid metabolism and other aspects of aging.
They also plan to investigate whether the approach works similarly in females. These questions matter before the experimental strategy can be understood more broadly.
The study did not test a diet, supplement, probiotic, or self-care plan for increasing BSH activity. Its intervention was a specifically engineered bacterial strain used in mice.
There is therefore no basis here for seeking engineered bacteria or assuming that an available gut-health product reproduces the experiment. The research also provides no grounds for choosing a food according to an assumed ability to increase BSH. Decisions involving personal symptoms or medical treatment belong with a qualified healthcare professional.
Zarrinpar described the longer-term goal as identifying beneficial microbial functions and determining whether they can be safely strengthened to support healthier aging. That is a research direction centered on understanding a function before putting it to use.
A useful next advance would connect a clearly defined microbial intervention with meaningful outcomes in people. That would address a different question from finding an interesting pattern among those who have already lived exceptionally long lives.
For everyday eating, the sensible response is to avoid turning BSH into a dietary target. Questions about meals belong within a broader assessment of the evidence behind microbiome-focused diets, not a race to act on one enzyme finding.
The study gives researchers a more focused question about aging. For readers, its value is a clearer understanding that microbial activity deserves attention alongside microbial identity. It is a reason to follow the science carefully rather than reorganize daily food choices around a longevity promise.
A microbial enzyme linked with longevity creates a gap between an intriguing biological finding and a useful food decision. DigestGenius addresses the difficulty of separating promising research from established evidence through free articles and detailed resources on digestion and microbiome science, helping adults place findings like these in context without treating them as dietary prescriptions.
DigestGenius publishes research-led guidance on digestion, the gut microbiome, fiber, probiotics, gut-brain signaling, inflammation and everyday digestive wellbeing.



Explore clear, research-led guidance on digestion, the microbiome, food, fiber, probiotics and the gut-brain connection.
read the blog